Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunol ; 194(11): 5497-508, 2015 Jun 01.
Article in English | MEDLINE | ID: mdl-25904551

ABSTRACT

Engineering of the constant Fc part of monoclonal human IgG1 (hIgG1) Abs is an approach to improve effector functions and clinical efficacy of next-generation IgG1-based therapeutics. A main focus in such development is tailoring of in vivo half-life and transport properties by engineering the pH-dependent interaction between IgG and the neonatal Fc receptor (FcRn), as FcRn is the main homeostatic regulator of hIgG1 half-life. However, whether such engineering affects binding to other Fc-binding molecules, such as the classical FcγRs and complement factor C1q, has not been studied in detail. These effector molecules bind to IgG1 in the lower hinge-CH2 region, structurally distant from the binding site for FcRn at the CH2-CH3 elbow region. However, alterations of the structural composition of the Fc may have long-distance effects. Indeed, in this study we show that Fc engineering of hIgG1 for altered binding to FcRn also influences binding to both the classical FcγRs and complement factor C1q, which ultimately results in alterations of cellular mechanisms such as Ab-dependent cell-mediated cytotoxicity, Ab-dependent cellular phagocytosis, and Ab-dependent complement-mediated cell lysis. Thus, engineering of the FcRn-IgG1 interaction may greatly influence effector functions, which has implications for the therapeutic efficacy and use of Fc-engineered hIgG1 variants.


Subject(s)
Antibodies, Monoclonal/genetics , Complement C1q/immunology , Histocompatibility Antigens Class I/immunology , Immunoglobulin G/genetics , Receptors, Fc/immunology , Receptors, IgG/immunology , Antibodies, Monoclonal/immunology , Antibody Affinity/genetics , Antibody Affinity/immunology , Antibody-Dependent Cell Cytotoxicity/immunology , Cell Line , HEK293 Cells , Hinge Exons/genetics , Histocompatibility Antigens Class I/genetics , Humans , Immunoglobulin G/immunology , Nitrohydroxyiodophenylacetate/immunology , Phagocytosis/immunology , Protein Engineering , Receptors, Fc/genetics , Receptors, IgG/genetics , Surface Plasmon Resonance
2.
Nat Immunol ; 16(5): 534-43, 2015 May.
Article in English | MEDLINE | ID: mdl-25848865

ABSTRACT

Mature B cells express immunoglobulin M (IgM)- and IgD-isotype B cell antigen receptors, but the importance of IgD for B cell function has been unclear. By using a cellular in vitro system and corresponding mouse models, we found that antigens with low valence activated IgM receptors but failed to trigger IgD signaling, whereas polyvalent antigens activated both receptor types. Investigations of the molecular mechanism showed that deletion of the IgD-specific hinge region rendered IgD responsive to monovalent antigen, whereas transferring the hinge to IgM resulted in responsiveness only to polyvalent antigen. Our data suggest that the increased IgD/IgM ratio on conventional B-2 cells is important for preferential immune responses to antigens in immune complexes, and that the increased IgM expression on B-1 cells is essential for B-1 cell homeostasis and function.


Subject(s)
B-Lymphocytes/immunology , Immunoglobulin D/immunology , Immunoglobulin M/immunology , Animals , Antigen-Antibody Complex/immunology , Antigens/immunology , Binding Sites, Antibody/immunology , Calcium Signaling/genetics , Cell Differentiation , Cell Line , Hinge Exons/genetics , Homeostasis/genetics , Immunity, Humoral/genetics , Immunoglobulin D/genetics , Immunoglobulin M/genetics , Mice , Mice, Knockout , Protein Engineering , Sequence Deletion/genetics
3.
MAbs ; 2(3): 212-20, 2010.
Article in English | MEDLINE | ID: mdl-20400859

ABSTRACT

The effective functioning of immunoglobulins and IgG mAbs in removing pathological cells requires that the antigen binding regions and the Fc (effector) domain act in concert. The hinge region that connects these domains itself presents motifs that engage Fc receptors on immune effector cells to achieve cell lysis. In addition, sequences in the lower hinge/CH2 and further down the CH2 region are involved in C1q binding and complement-mediated cell killing. Proteolytic enzymes of little relevance to human physiology were successfully used for decades to generate fragments of IgGs for reagent and therapeutic use. It was subsequently noted that tumor-related and microbial proteases also cleaved human IgG specifically in the hinge region. We have shown previously that the "nick" of just one of the lower hinge heavy chains of IgG unexpectedly prevented many effector functions without impacting antigen binding. Of interest, related single-cleaved IgG breakdown products were detected in breast carcinoma extracts. This suggested a pathway by which tumors might avoid host immune surveillance under a cloak of proteolytically-generated, dysfunctional antibodies that block competent IgG binding. The host immune system cannot be blind to this pathway since there exists a widespread, low-titer incidence of anti-hinge (cleavage-site) antibodies in the healthy population. The prevalence of anti-hinge reactivity may reflect an ongoing immune recognition of normal IgG catabolism. Tumor growth and bacterial infections potentially generate hostile proteolytic environments that may pose harsh challenges to host immunity. Recent findings involving physiologically-relevant proteases suggest that the potential loss of key effector functions of host IgGs may result from subtle and limited proteolytic cleavage of IgGs and that such events may facilitate the incursion of invasive cells in local proteolytic settings.


Subject(s)
Bacterial Infections/enzymology , Bacterial Infections/immunology , Immune Evasion , Immunoglobulin G/metabolism , Neoplasms/enzymology , Neoplasms/immunology , Peptide Hydrolases/metabolism , Tumor Escape , Amino Acid Sequence , Animals , Antibodies, Monoclonal/metabolism , Autoantibodies/immunology , Bacterial Infections/therapy , Bacterial Proteins/metabolism , Hinge Exons/genetics , Hinge Exons/immunology , Humans , Immunoglobulin G/immunology , Molecular Sequence Data , Neoplasms/therapy
4.
Drug Metab Dispos ; 38(1): 84-91, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19850673

ABSTRACT

The IgG4 isotype antibody is a potential candidate for immunotherapy when reduced effector functions are desirable. However, antigen binding fragment (Fab) arm exchange leads to functional monovalency with potentially reduced therapeutic efficacy. Mutagenesis studies suggested that the CH3 domain and not the core hinge is dominantly involved in in vivo molecular processing. This work investigated whether stabilization of the core hinge of a therapeutic IgG4 antibody by mutation of Ser228 to Pro (S228P) would be sufficient to prevent in vivo Fab arm exchange. In vitro experiments evaluated the influence of different levels of oxidation-reduction conditions in buffer and serum on Fab arm exchange (swapping) of wild-type (WT) IgG4 and IgG1 and of IgG4 S228P, which included a sterically neutral second mutation (Leu235 replaced by Glu). The objective of single-dose pharmacokinetic experiments in cynomolgus monkeys was to determine whether the mutation reduced IgG4 swapping in vivo. The results indicated that S228P mutation did not completely prevent Fab arm exchange in vitro in buffer under reducing conditions relative to IgG4 WT. The immunoassay findings were confirmed by mass spectrometry measurements. Results of the in vivo studies suggested that the therapeutic IgG4 WT antibody exchanged Fab arms with endogenous cynomolgus monkey IgG4, resulting in bispecific IgG4 antibodies with monovalency for the therapeutic target. In contrast, serum from cynomolgus monkeys dosed with the IgG4 mutant was virtually free of swapped IgG4. In conclusion, the results indicated that IgG4 swapping in vivo was markedly attenuated by S228P mutation.


Subject(s)
Antibodies, Monoclonal/metabolism , Antibodies, Monoclonal/pharmacokinetics , Hinge Exons/genetics , Immunoglobulin G/metabolism , Immunoglobulin G/therapeutic use , Recombinant Proteins/pharmacokinetics , Amino Acid Substitution/genetics , Amino Acid Substitution/immunology , Animals , Antibodies, Bispecific/immunology , Antibodies, Bispecific/metabolism , Antibodies, Bispecific/pharmacokinetics , Antibodies, Monoclonal/genetics , Antibodies, Monoclonal/therapeutic use , Buffers , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunoglobulin Fab Fragments/immunology , Immunoglobulin Fab Fragments/metabolism , Immunoglobulin G/genetics , Macaca fascicularis , Male , Mice , OX40 Ligand/immunology , Oxidation-Reduction , Rats , Receptors, Interleukin-1/immunology , Receptors, Interleukin-13/immunology , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Recombinant Proteins/metabolism , Reducing Agents/metabolism , Serum/immunology , Serum/metabolism , Spectrometry, Mass, Electrospray Ionization
5.
J Exp Med ; 206(1): 153-67, 2009 Jan 16.
Article in English | MEDLINE | ID: mdl-19114667

ABSTRACT

The intronic enhancer (E mu) of the immunoglobulin heavy chain (IgH) locus is critical for V region gene assembly. To determine E mu's subsequent functions, we created an Igh allele with assembled V(H) gene but with E mu removed. In mice homozygous for this E mu-deficient allele, B cell development was normal and indistinguishable from that of mice with the same V(H) knockin and E mu intact. In mice heterozygous for the E mu-deficient allele, however, allelic exclusion was severely compromised. Surprisingly, this was not a result of reduced suppression of V-DJ assembly on the second allele. Rather, the striking breakdown in allelic exclusion took place at the pre-B to immature B cell transition. These findings reveal both an important role for E mu in influencing the fate of newly arising B cells and a second checkpoint for allelic exclusion.


Subject(s)
Alleles , Enhancer Elements, Genetic/genetics , Genes, Immunoglobulin Heavy Chain/genetics , Immunoglobulin mu-Chains/genetics , Animals , B-Lymphocyte Subsets/chemistry , B-Lymphocyte Subsets/cytology , B-Lymphocyte Subsets/metabolism , B-Lymphocytes/cytology , B-Lymphocytes/metabolism , Bone Marrow Cells/cytology , Bone Marrow Cells/metabolism , Cell Differentiation/genetics , Cell Differentiation/immunology , Gene Expression/genetics , Gene Rearrangement, B-Lymphocyte, Heavy Chain/genetics , Hinge Exons/genetics , Homeodomain Proteins/genetics , Immunoglobulin D/analysis , Immunoglobulin Heavy Chains/genetics , Immunoglobulin Heavy Chains/metabolism , Immunoglobulin M/analysis , Immunoglobulin M/genetics , Immunoglobulin kappa-Chains/genetics , Immunoglobulin kappa-Chains/metabolism , Immunoglobulin lambda-Chains/genetics , Immunoglobulin lambda-Chains/metabolism , Immunoglobulin mu-Chains/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Receptors, Antigen, B-Cell/analysis , Receptors, Antigen, B-Cell/genetics , Spleen/cytology , VDJ Exons/genetics
6.
Drug Metab Dispos ; 35(9): 1489-94, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17567731

ABSTRACT

Translocation of constitutive androstane receptor (CAR) from the cytoplasm to the nucleus is induced by phenobarbital-like drugs. Nuclear localization signals (NLSs) and a sequence [xenochemical response signal (XRS)] required for xenobiotic-induced nuclear translocation have been defined in rat and human CAR, but a nuclear export signal (NES) has not been identified. To identify cellular localization signals of CAR, the localization of fragments and mutants of mouse CAR expressed in mouse hepatocytes in vivo was examined. Consistent with other studies, an NLS in the hinge region, a diffuse NLS in the ligand-binding domain, and a cytoplasmic retention sequence were identified, and mutation of the XRS blocked nuclear accumulation both in phenobarbital-treated mice in vivo and in untreated HepG2 cells. Fusing the simian virus 40 NLS to the mutant proteins reversed the localization defect resulting from mutation of the hinge NLS but not that from mutation of the XRS, indicating that the XRS is not simply a novel phenobarbital-responsive NLS. In the DNA-binding domain, a sequence in CAR is conserved with an NES identified in other nuclear receptors. Mutation of two conserved phenylalanines in this sequence resulted in increased nuclear localization of both full-length CAR and a CAR fragment containing the DNA-binding domain. The DNA-binding domain sequence, therefore, may contain an NES, which is consistent with nucleocytoplasmic shuttling of CAR. The results demonstrate that regulation of the cellular localization of CAR is complex, with multiple sequences mediating nuclear import and export and retention in the cytoplasm.


Subject(s)
Active Transport, Cell Nucleus/physiology , DNA/metabolism , Receptors, Cytoplasmic and Nuclear/physiology , Signal Transduction/physiology , Subcellular Fractions/metabolism , Transcription Factors/physiology , Animals , Carrier Proteins/metabolism , Cell Line , Cell Line, Tumor , Constitutive Androstane Receptor , DNA-Binding Proteins , Green Fluorescent Proteins/metabolism , Hepatocytes/drug effects , Hepatocytes/metabolism , Hinge Exons/genetics , Humans , Ligands , Mice , Mutation/genetics , Nuclear Proteins/metabolism , Plasmids/genetics , RNA-Binding Proteins , Rats
7.
J Immunol Methods ; 313(1-2): 214-8, 2006 Jun 30.
Article in English | MEDLINE | ID: mdl-16820167

ABSTRACT

We describe an easy method for the production of small recombinant peptides of 8 amino acid residues expressed as a fusion peptide with glutathione S-transferase (GST) and employed in an immunisation schedule to obtain polyclonal antibodies. The chosen peptides corresponded to specific fragments of the hinge regions of llama (Lama glama) IgG2 subisotypes b (2bH) and c (2cH). The DNA sequences encoding each peptide were ligated individually into pGEX-5X-2, which encodes GST. Once purified from a bacterial lysate by glutathione affinity chromatography, GST-2bH and GST-2cH were used to immunize rabbits. In parallel, polyclonal antibodies were generated against specific synthetic fragments of the hinge regions of llama IgG2a (2aH) and IgG3 (3H) coupled to keyhole limpet haemocyanin (KLH). Polyclonal antibodies raised against GST-peptides and KLH-peptides were detected by enzyme-linked immunosorbent assay (ELISA), Western blot (WB) and indirect immunofluorescence (IIF). The results obtained by ELISA demonstrated that monospecific anti-IgG2 and anti-IgG3 antisera were obtained using KLH-2aH, GST-2bH, GST-2cH and KLH-3H as antigens. All antisera showed reactivity with their specific IgG isotype by WB and IIF. This simple and novel recombinant DNA methodology for the generation of two monospecific anti-isotype antisera using small peptides expressed as fusion peptides with GST offers the possibility of large scale peptide production as an alternative to chemical peptide synthesis.


Subject(s)
Camelids, New World/immunology , Immune Sera/immunology , Immunoglobulin G/immunology , Recombinant Fusion Proteins/immunology , Animals , Cross Reactions/immunology , Enzyme-Linked Immunosorbent Assay , Escherichia coli/genetics , Genetic Vectors/genetics , Hinge Exons/genetics , Immunoglobulin Fragments/biosynthesis , Immunoglobulin Fragments/genetics , Immunoglobulin Fragments/immunology , Lymphocytes/chemistry , Lymphocytes/immunology , Microscopy, Fluorescence , Peptides/genetics , Peptides/immunology , Rabbits , Recombinant Fusion Proteins/biosynthesis
8.
Int J Immunogenet ; 33(3): 171-7, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16712647

ABSTRACT

Unlike other species, European rabbit (Oryctolagus cuniculus) possesses only one immunoglobulin gamma class. Allelic diversity at the Ig (immunoglobulin) gamma constant region encoded by the unique IGHG (immunoglobulin heavy gamma) gene is moreover much reduced. In the European rabbit, the genetic variation at IGGH hinge region is limited to a single nucleotide substitution, which causes a Met-Thr interchange at amino acid position 9 (IMGT hinge numbering). We have analysed the diversity at this region more in-depth by, (1) analysing the allelic variation in 11 breeds of domestic European rabbit (Oryctolagus cuniculus cuniculus), and (2) sequencing the gamma hinge exon in wild specimens of six species of rabbit (Oryctolagus and Sylvilagus) and hares (Lepus), including the two Oryctolagus subspecies (O. cuniculus cuniculus and O. cuniculus algirus). It appeared that among leporid species, amino acid changes occur exclusively at positions 8 and 9. However, while position 8 is occupied by either Pro or Ser residues, four different residues can occur at position 9 (Met, Thr, Pro and Leu). This variation concerns sites of potential O-glycosylation and/or proteolytic cleavage, suggesting that the underlying genetic diversity could be the outcome of selection. Preservation of the gamma hinge polymorphism in domestic stocks could therefore be important. We report here a polymerase chain reaction/restriction fragment length polymorphism protocol that has allowed the monitoring of the heterozygosity levels at the gamma hinge in 11 breeds of domestic European rabbit.


Subject(s)
Alleles , Genetic Variation , Hares/genetics , Hinge Exons/genetics , Immunoglobulin gamma-Chains/genetics , Polymorphism, Restriction Fragment Length , Animals , Genetic Variation/immunology , Hares/immunology , Hinge Exons/immunology , Immunoglobulin gamma-Chains/immunology , Protein Processing, Post-Translational/genetics , Protein Processing, Post-Translational/immunology , Rabbits , Selection, Genetic , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...